These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 23860938

  • 1. Transjugular intrahepatic portosystemic shunt for the treatment of Budd-Chiari syndrome patients: results from a single center.
    Fitsiori K, Tsitskari M, Kelekis A, Filippiadis D, Triantafyllou K, Brountzos E.
    Cardiovasc Intervent Radiol; 2014 Jun; 37(3):691-7. PubMed ID: 23860938
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcome of a covered vs. uncovered transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome.
    Darwish Murad S, Luong TK, Pattynama PM, Hansen BE, van Buuren HR, Janssen HL.
    Liver Int; 2008 Feb; 28(2):249-56. PubMed ID: 18251982
    [Abstract] [Full Text] [Related]

  • 3. Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management.
    Rautou PE, Moucari R, Escolano S, Cazals-Hatem D, Denié C, Chagneau-Derrode C, Charpignon C, Lédinghen Vd, Grenouillet-Delacre M, Habersetzer F, Nousbaum JB, Denninger MH, Valla DC, Plessier A.
    Am J Gastroenterol; 2009 May; 104(5):1140-6. PubMed ID: 19337247
    [Abstract] [Full Text] [Related]

  • 4. Transjugular intrahepatic portosystemic shunt patency and clinical outcome in patients with Budd-Chiari syndrome: covered versus uncovered stents.
    Gandini R, Konda D, Simonetti G.
    Radiology; 2006 Oct; 241(1):298-305. PubMed ID: 16908675
    [Abstract] [Full Text] [Related]

  • 5. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients.
    Garcia-Pagán JC, Heydtmann M, Raffa S, Plessier A, Murad S, Fabris F, Vizzini G, Gonzales Abraldes J, Olliff S, Nicolini A, Luca A, Primignani M, Janssen HL, Valla D, Elias E, Bosch J, Budd-Chiari Syndrome-Transjugular Intrahepatic Portosystemic Shunt Group.
    Gastroenterology; 2008 Sep; 135(3):808-15. PubMed ID: 18621047
    [Abstract] [Full Text] [Related]

  • 6. Validation of prognostic indices in Egyptian Budd-Chiari syndrome patients: A single-center study.
    Sakr M, Abdelhakam SM, Elsayed SA, Allam EH, Farid AM, Abdelmoaty W, Hassan AM, Shaker M, El-Gharib M, Eldorry A.
    World J Gastroenterol; 2017 Jan 28; 23(4):629-637. PubMed ID: 28216969
    [Abstract] [Full Text] [Related]

  • 7. Good long-term outcome of Budd-Chiari syndrome with a step-wise management.
    Seijo S, Plessier A, Hoekstra J, Dell'era A, Mandair D, Rifai K, Trebicka J, Morard I, Lasser L, Abraldes JG, Darwish Murad S, Heller J, Hadengue A, Primignani M, Elias E, Janssen HL, Valla DC, Garcia-Pagan JC, European Network for Vascular Disorders of the Liver.
    Hepatology; 2013 May 28; 57(5):1962-8. PubMed ID: 23389867
    [Abstract] [Full Text] [Related]

  • 8. Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome.
    Tripathi D, Macnicholas R, Kothari C, Sunderraj L, Al-Hilou H, Rangarajan B, Chen F, Mangat K, Elias E, Olliff S.
    Aliment Pharmacol Ther; 2014 Apr 28; 39(8):864-72. PubMed ID: 24611957
    [Abstract] [Full Text] [Related]

  • 9. Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt.
    Khuroo MS, Al-Suhabani H, Al-Sebayel M, Al Ashgar H, Dahab S, Khan MQ, Khalaf HA.
    J Gastroenterol Hepatol; 2005 Oct 28; 20(10):1494-502. PubMed ID: 16174064
    [Abstract] [Full Text] [Related]

  • 10. Transjugular Intrahepatic Portosystemic Shunt Through the Strut of a Previously Placed Stent: Technical Feasibility and Long-Term Follow-Up Results.
    Ahmed M, Keshava SN, Moses V, Chiramel GK, Mammen S, Eapen CE, Zachariah UG.
    Cardiovasc Intervent Radiol; 2018 Nov 28; 41(11):1794-1798. PubMed ID: 30014251
    [Abstract] [Full Text] [Related]

  • 11. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems.
    Ganger DR, Klapman JB, McDonald V, Matalon TA, Kaur S, Rosenblate H, Kane R, Saker M, Jensen DM.
    Am J Gastroenterol; 1999 Mar 28; 94(3):603-8. PubMed ID: 10086638
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term Outcome and Analysis of Dysfunction of Transjugular Intrahepatic Portosystemic Shunt Placement in Chronic Primary Budd-Chiari Syndrome.
    Hayek G, Ronot M, Plessier A, Sibert A, Abdel-Rehim M, Zappa M, Rautou PE, Valla D, Vilgrain V.
    Radiology; 2017 Apr 28; 283(1):280-292. PubMed ID: 27797679
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T, Safka V, Hůlek P, Vanásek T, Krajina A, Jirkovský V.
    Vnitr Lek; 2006 Sep 28; 52(9):771-6. PubMed ID: 17091599
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcomes of transjugular intrahepatic portosystemic shunt in Indian patients with Budd-Chiari syndrome.
    Shalimar, Gamanagatti SR, Patel AH, Kedia S, Nayak B, Gunjan D, Ranjan G, Paul SB, Acharya SK.
    Eur J Gastroenterol Hepatol; 2017 Oct 28; 29(10):1174-1182. PubMed ID: 28763339
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.